Delivery Order SPE2DX22D0010-SPE2D824FLP66
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,799.28 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,763,686 units of Vyvanse 30 mg capsules. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,555,283 units of Vyvanse 30 mg capsules. The contract has a potential value of $4,074.18 and a completion date of February 6, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a potential...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distributor. The $1,665.00 firm fixed price contract is for the delivery of 100 units of Vyvanse 60 mg capsules. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued up to $999,999,999.00 and running through...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order contract valued at $2,662.44 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 100 units of Vyvanse 40 mg capsules. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Vyvanse 10 mg capsules. The $1,293.00 Firm Fixed Price contract has an ultimate completion date of October 31, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- The U.S. government, specifically the Defense Logistics Agency (DLA) Troop Support Medical, awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $59,862.41 contract is for the delivery of Vyvanse (Lisdexamfetamine Dimesylate) 50mg capsules. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp, which serves as the...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $10,838.56 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,564,734,299 units of the prescription medication Vyvanse (60mg capsules) over a period ending on May 30, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, serving as the primary vehicle for the company to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 30 mg Vyvanse capsules. The $1,718.34 contract has a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $10,833.45 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,559,778,029 units of Vyvanse 30 mg capsules. The contract has a firm fixed price and an ultimate completion date of January 31, 2023. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026, which...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,072.00 fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,556 units of Vyvanse 30 mg capsules. This contract has an ultimate completion date of August 22, 2024 and is not associated with any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D824FLP66Delivery Order
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Vyvanse capsules in the 30mg dosage. The contract has a ceiling value of $9,555.79 and a period of performance through April 11, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp to supply a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The IDC has a potential total value of $999,999,999.00 and runs through December 31, 2025. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.6k | 4/10/24 |